Nektar Therapeutics (NKTR) Other Non Operating Income (2016 - 2025)
Nektar Therapeutics has reported Other Non Operating Income over the past 16 years, most recently at -$44000.0 for Q4 2025.
- Quarterly results put Other Non Operating Income at -$44000.0 for Q4 2025, up 67.41% from a year ago — trailing twelve months through Dec 2025 was $361000.0 (up 192.56% YoY), and the annual figure for FY2025 was $361000.0, up 192.56%.
- Other Non Operating Income for Q4 2025 was -$44000.0 at Nektar Therapeutics, up from -$121000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for NKTR hit a ceiling of $33.4 million in Q1 2022 and a floor of -$6.3 million in Q4 2023.
- Median Other Non Operating Income over the past 5 years was -$109500.0 (2024), compared with a mean of $1.2 million.
- Biggest five-year swings in Other Non Operating Income: soared 2190.49% in 2022 and later plummeted 116.34% in 2023.
- Nektar Therapeutics' Other Non Operating Income stood at -$2.6 million in 2021, then surged by 180.39% to $2.0 million in 2022, then plummeted by 409.61% to -$6.3 million in 2023, then skyrocketed by 97.87% to -$135000.0 in 2024, then soared by 67.41% to -$44000.0 in 2025.
- The last three reported values for Other Non Operating Income were -$44000.0 (Q4 2025), -$121000.0 (Q3 2025), and $260000.0 (Q2 2025) per Business Quant data.